Overview

Why attend C21 BioVentures?

Private Companies Building Relationships and Opportunities
Featuring presentations from 66 innovative private companies, C21 provides the right audience to help companies meet their financing goals and objectives.

Pharmaceutical Companies Building Portfolios
C21 provides pharma with a focused approach to finding the most qualified targets to partner with, giving them early access to new candidates to add to their existing product portfolios and pipelines.

Venture Capital Seeking New Opportunities for Investment
With a focus on private companies seeking investors, C21 provides excellent early stage opportunities for venture capitalists and institutional investors.

Who is attending C21 BioVentures?

The graphs below offer a break down on the type of companies and individuals who regularly attend C21 and make it a high value conference.

Companies: The right mix of key life science sectors

Attendees: Over 85% are key executive decision makers

Investors
Click here to view attending investor companies.
Speakers
Click here to view confirmed speakers for this year's conference.
Advisory Board
Click here to view the C21 advisory board comprised of leading investment firms.
Presenting Companies
Click here to view the private companies selected to present at C21.
Companies Attending
Click here to view a list of companies registered for C21 thus far.

testimonial

Overview

OUR CONFERENCES

AFFILIATE CONFERENCES

		10th Anniversary C21 BioVentures May 20-22, 2008 \| Napa, California, USA

		Home Overview Partnering Program Participants Media Travel FAQ

	Overview testimonial "C21 provides a fun, relaxing yet informative environment to see new companies and network with the top venture investors. It is a must attend event!" - J. Norris Silicon Valley Bank Overview Why attend C21 BioVentures? Private Companies Building Relationships and Opportunities Featuring presentations from 66 innovative private companies, C21 provides the right audience to help companies meet their financing goals and objectives. Pharmaceutical Companies Building Portfolios C21 provides pharma with a focused approach to finding the most qualified targets to partner with, giving them early access to new candidates to add to their existing product portfolios and pipelines. Venture Capital Seeking New Opportunities for Investment With a focus on private companies seeking investors, C21 provides excellent early stage opportunities for venture capitalists and institutional investors. Who is attending C21 BioVentures? The graphs below offer a break down on the type of companies and individuals who regularly attend C21 and make it a high value conference. Companies: The right mix of key life science sectors Attendees: Over 85% are key executive decision makers Investors Click here to view attending investor companies. Speakers Click here to view confirmed speakers for this year's conference. Advisory Board Click here to view the C21 advisory board comprised of leading investment firms. Presenting Companies Click here to view the private companies selected to present at C21. Companies Attending Click here to view a list of companies registered for C21 thus far.